EDGAR Filing Documents for 0001104659-16-107410

Form 8-K - Current report:

SEC Accession No. 0001104659-16-107410

Filing Date

2016-03-24

Accepted

2016-03-24 16:01:22

Documents

Period of Report

2016-03-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-7143_18k.htm	8-K	26738
2	EX-1.1	a16-7143_1ex1d1.htm	EX-1.1	242811
3	EX-5.1	a16-7143_1ex5d1.htm	EX-5.1	9108
4	EX-99.1	a16-7143_1ex99d1.htm	EX-99.1	14375
5	GRAPHIC	g71431mmi001.gif	GRAPHIC	1481
	Complete submission text file	0001104659-16-107410.txt		296452

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034

Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000

Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 161527046
SIC: 2834 Pharmaceutical Preparations